GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature.

Patrizia QuerzoliMassimo Pedriali Rosa RinaldiPaola SecchieroPaolo Giorgi RossiElisabetta Kuhn

Published in: Diagnostics (Basel, Switzerland) (2021)

Our findings indicate that GATA3 is a positive prognostic marker in BC patients, especially in patients with biologically less aggressive BC. Incorporating GATA3 immunohistochemistry into routine practice could help further stratify BC patients for their risk.

Keyphrases

prognostic factors
end stage renal disease
ejection fraction
transcription factor
healthcare
peritoneal dialysis
patient reported outcomes